To confirm the presence of elevated CD73 protein expression in CNS tumors, we used immunohistochemistry (IHC) to systematically characterize CD73 levels in tissue sections from 605 human brain tumors of most major histologic subtypes obtained from the BWH archives and the Children’s Brain Tumor Network (CBTN) (Fig. 4B–D; Supplementary Data 5, antibodies used in this study are listed in Supplementary Table 1). The gene discussed is NT5E; the disease is central nervous system neoplasm.